In large-core stroke, EVT was associated with significantly attenuated oedema progression, and reduced ischaemic water uptake was strongly associated with EVT benefit on 90-day functional outcome in mediation models, supporting oedema attenuation as a plausible mechanistic pathway of EVT benefit.
Key Findings
Results
EVT was associated with substantially lower oedema progression in large-core stroke patients compared to those without EVT.
Median delta net water uptake (ΔNWU) was 4.7% in the EVT group versus 15.9% in the non-EVT group
The difference was statistically significant (P < .001)
The study population consisted of 177 patients from the randomised TENSION trial
Patients had anterior circulation ischaemic stroke with baseline ASPECTS 3-5
Results
Reduced oedema formation (ΔNWU) mediated an estimated 34% of EVT-related improvement in 90-day modified Rankin Scale.
Mediation analysis estimated that 34% of EVT's treatment effect on functional outcome was associated with ΔNWU
In contrast, only 14% of the treatment effect was associated with lesion extent change (ΔASPECTS)
In a sensitivity analysis using nonparametric bootstrap with 5000 resamples, the mediation signal remained robust for ΔNWU but was substantially weaker for ΔASPECTS
Functional outcome was assessed as 90-day modified Rankin Scale (mRS) using ordinal logistic regression
Results
Both ΔNWU and ΔASPECTS were independently associated with 90-day functional outcome in ordinal logistic regression analyses.
Associations of ΔNWU and ΔASPECTS with 90-day mRS were tested using ordinal logistic regression
ΔNWU was quantified as the change in CT-based net water uptake between baseline and follow-up non-contrast CT, derived from relative hypoattenuation within the infarct
ΔASPECTS was assessed as the difference in ASPECTS between baseline and follow-up imaging
Median follow-up NWU was 28.5% (IQR: 19.2–36.6) and follow-up ASPECTS was 2 (IQR: 1–3)
Methods
The study used CT-based net water uptake (NWU) as a quantitative measure of ischaemic oedema progression in large-core stroke patients.
NWU was derived from relative hypoattenuation within the infarct on non-contrast CT
Oedema progression was quantified as the change in NWU (ΔNWU) between baseline and follow-up imaging
The analysis was a secondary analysis of the randomised TENSION trial enrolling patients with ASPECTS 3-5
177 patients were included in the analysis
Discussion
Oedema attenuation is proposed as a plausible mechanistic pathway through which EVT improves functional outcomes in large-core stroke, independent of changes in lesion extent.
The mediation proportion attributed to ΔNWU (34%) was larger than that attributed to ΔASPECTS (14%), suggesting oedema reduction contributes to outcome improvement beyond lesion size reduction
The hypothesis was that EVT reduces ischaemic oedema formation and that attenuation of oedema mediates functional outcome improvement beyond changes in lesion extent
The mediation signal for ΔNWU remained robust in sensitivity analyses with 5000 bootstrap resamples, while the signal for ΔASPECTS was substantially weaker
Authors concluded that reduced ischaemic water uptake was 'strongly associated with EVT benefit on 90-day functional outcome in mediation models'
What This Means
This research examined why mechanical clot removal (thrombectomy) helps patients who have had large strokes, specifically those with extensive brain damage visible on initial scans. The study analyzed data from 177 patients in a clinical trial and found that patients who received thrombectomy had much less brain swelling (oedema) over time compared to those who did not — the measure of water accumulation in the damaged brain tissue increased by only 4.7% in treated patients versus 15.9% in untreated patients.
Using statistical mediation analysis, the researchers estimated that about 34% of the functional benefit of thrombectomy at 90 days could be explained by this reduction in brain swelling, while only about 14% was explained by the reduction in the size of the damaged area. This suggests that thrombectomy helps patients not only by limiting how much brain tissue dies, but also by reducing the harmful swelling that occurs in already-damaged tissue — and that this swelling reduction is actually a more important part of the benefit than previously appreciated.
This research suggests that brain oedema (swelling caused by water accumulation in damaged tissue) is a key mechanism through which restoring blood flow benefits large-stroke patients. This could have implications for how researchers think about developing new treatments and measuring outcomes in large-core stroke — specifically, that treatments targeting brain swelling might offer additional benefit, and that oedema measurements on CT scans could serve as useful markers in future studies.
Broocks G, Bendszus M, Simonsen C, Thomalla G, Gizewski E, Aamodt A, et al.. (2026). Oedema reduction mediates thrombectomy benefit in large core stroke: secondary analysis of the TENSION trial.. European stroke journal. https://doi.org/10.1093/esj/aakag055